As noted in the first article in our Medtech Coming to America series, “US Emerging as Top Global Medtech Destination,” perceived regulatory advantages are prompting European medtechs to enter the US ...

Reforming the patent system for brand-name drugs in the United States could be more effective than changes to nonpatent exclusivities in encouraging generic competition, according to an analysis of ...

Ways to make a better patent system is a common theme at IPWatchdog, and we are going to get even more seriously involved in that discussion over the next year as we try to bring thought leaders ...

The US Department of Commerce is reportedly considering a significant overhaul of the current patent maintenance fee structure, proposing a shift from the established flat-fee system to an annual, ...

As the US patent system tilts further toward favouring patent owners, firms with a strong patentee focus can get ahead of the game USPTO Director John Squires wasted no time in instituting several ...

Revolution MD, a leader in safe, controlled delivery of high-risk medications like opioids and other controlled substances today announced the issuance of its patent for a groundbreaking global drug ...